Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-06 4:34 pm Purchase | 13D | BioRestorative Therapies Inc. BRTX | Broadrick Dale | 926,376 14.100% | 314,631 (+51.43%) | View |
2024-02-15 4:43 pm Purchase | 13D | BioRestorative Therapies Inc. BRTX | Silva Francisco | 764,557 10.700% | 764,557 (New Position) | View |
2024-02-15 4:40 pm Purchase | 13D | BioRestorative Therapies Inc. BRTX | ALSTODT LANCE | 799,136 11.200% | 799,136 (New Position) | View |
2024-02-14 1:44 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | Auctus Fund Management LLC | 482,315 9.900% | 106,311 (+28.27%) | View |
2023-02-17 5:25 pm Sale | 13D | BioRestorative Therapies Inc. BRTX | Silva Francisco | 505,125 12.500% | -595,201,924 (-99.92%) | View |
2023-02-17 5:24 pm Sale | 13D | BioRestorative Therapies Inc. BRTX | ALSTODT LANCE | 513,784 12.700% | -605,156,869 (-99.92%) | View |
2023-02-14 1:02 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | Auctus Fund Management LLC | 376,004 9.900% | 166,004 (+79.05%) | View |
2023-02-07 4:42 pm Sale | 13G | BioRestorative Therapies Inc. BRTX | Hudson Bay Capital Management LP | 0 0.000% | -200,000 (Position Closed) | View |
2022-07-14 5:26 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | Auctus Fund Management LLC | 210,000 5.800% | 210,000 (New Position) | View |
2022-06-21 10:17 am Purchase | 13D | BioRestorative Therapies Inc. BRTX | Broadrick Dale | 611,745 16.800% | 41,561 (+7.29%) | View |
2022-04-07 4:08 pm Purchase | 13D | BioRestorative Therapies Inc. BRTX | Broadrick Dale | 570,184 15.700% | 61,700 (+12.13%) | View |
2022-03-29 4:46 pm Purchase | 13D | BioRestorative Therapies Inc. BRTX | Broadrick Dale | 508,484 14.600% | 508,484 (New Position) | View |
2022-02-14 06:07 am Unchanged | 13G | BioRestorative Therapies Inc. BRTX | Altium Capital Management LP | 200,000 4.990% | 0 (Unchanged) | View |
2022-02-02 4:30 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | Hudson Bay Capital Management LP | 200,000 5.420% | 200,000 (New Position) | View |
2022-01-04 3:40 pm Sale | 13G | BioRestorative Therapies Inc. BRTX | SABBY MANAGEMENT LLC | 174,300 11.000% | -50,700 (-22.53%) | View |
2021-11-15 8:37 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | Altium Capital Management LP | 200,000 5.700% | 200,000 (New Position) | View |
2021-11-09 12:26 pm Purchase | 13G | BioRestorative Therapies Inc. BRTX | SABBY MANAGEMENT LLC | 225,000 11.000% | 225,000 (New Position) | View |
2021-03-19 4:54 pm Purchase | 13D | BioRestorative Therapies Inc. BRTX | Silva Francisco | 595,707,049 16.500% | 595,707,049 (New Position) | View |
2021-03-19 4:50 pm Purchase | 13D | BioRestorative Therapies Inc. BRTX | ALSTODT LANCE | 605,670,653 16.800% | 605,670,653 (New Position) | View |
2020-01-08 7:06 pm Purchase | 13D | BioRestorative Therapies Inc. BRTX | Broadrick Dale | 23,817,951 48.200% | 8,460,210 (+55.09%) | View |